HC/pIL-12/polyMET has a synergistic chemoimmunotherapy effect by increasing IFN-γ released by immune effector cells and inducing differentiation of tumor-associated macrophages into type M1 [162]. The gene discussed is IFNG; the disease is neoplasm.